Next report date
Report period
Q4 2023
EPS estimate
—
Revenue estimate
—
0.85CNY
338.75 MCNY
1.44 BCNY
211.04 M
About NINGBO MENOVO PHARMACEUTICAL
Sector
CEO
Cheng Zhi Yao
Headquarters
Ningbo
Website
Employees (FY)
2.3 K
Founded
2004
ISIN
CNE100002Y25
FIGI
BBG007N8QN02
Ningbo Menovo Pharmaceutical Co., Ltd. engages in the research, development, production and sales of specialty APIs and pharmaceutical intermediates. The company provides sales of pharmaceutical raw materials and intermediates, chemical raw materials and products, research and development of pharmaceutical raw materials, preparations, hard capsules and intermediates, self-operated or agency import and export business of various commodities and technologies, but the state Exceptions include goods and technologies that are prohibited or restricted from operation. Its products include pharmaceutical intermediates, active pharmaceutical ingredients, medical formulations, and finished medicines. The company was founded by Cheng Zhi Yao on February 19, 2004 and is headquartered in Ningbo, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 603538 is 12.77 CNY — it has increased by 0.47% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange NINGBO MENOVO PHARMACEUTICAL stocks are traded under the ticker 603538.
NINGBO MENOVO PHARMACEUTICAL is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
603538 stock is 2.07% volatile and has beta coefficient of 1.61. Check out the list of the most volatile stocks — is NINGBO MENOVO PHARMACEUTICAL there?
Yes, you can track NINGBO MENOVO PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
603538 stock has risen by 4.50% compared to the previous week, the month change is a 11.01% fall, over the last year NINGBO MENOVO PHARMACEUTICAL has showed a 43.89% decrease.
603538 net income for the last quarter is 23.68 M CNY, while the quarter before that showed −12.59 M CNY of net income which accounts for 288.05% change. Track more NINGBO MENOVO PHARMACEUTICAL financial stats to get the full picture.
Today NINGBO MENOVO PHARMACEUTICAL has the market capitalization of 2.69 B, it has increased by 2.31% over the last week.
Yes, 603538 dividends are paid annually. The last dividend per share was 0.17 CNY. As of today, Dividend Yield (TTM)% is 1.30%. Tracking NINGBO MENOVO PHARMACEUTICAL dividends might help you take more informed decisions.
NINGBO MENOVO PHARMACEUTICAL dividend yield was 0.64% in 2022, and payout ratio reached 10.25%. The year before the numbers were 0.56% and 20.68% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 603538 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NINGBO MENOVO PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 2.30 K employees. See our rating of the largest employees — is NINGBO MENOVO PHARMACEUTICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NINGBO MENOVO PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NINGBO MENOVO PHARMACEUTICAL stock shows the sell signal. See more of NINGBO MENOVO PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.